Find Your Local Office
Become A Member
Questions and Answers
Assess Your Joint Health
Disease Center
Learn About Arthritis
Drug Guide
Supplement Guide
Diet and Nutrition
Ask Dr. Klippel
Juvenile Arthritis
Joint Surgery Center
Pain Center
Alternative Therapies
Guide to Lab Tests
Glossary of Health Professionals
Exercise and Arthritis
Your Feet and Arthritis
51 Ways to Be Good to Your Joints
Message Boards
RA Connect
 
Back to Drug Guide Home    
From the 2005 Drug Guide

KID-SIZED DOSES
New legislation may help you - and doctors - be more confident
of the dose.

[Updated January 2007]

Dosage studies done on adults don't provide doctors with optimal dosing guidelines for children. Rather than guess what the best dose is - and risk guessing wrongly - many doctors choose to not prescribe potentially helpful "adult" drugs. Fortunately, the Pediatric Research Equity Act of 2003 is helping to eliminate the guesswork and giving doctors the information they need to prescribe helpful drugs they might otherwise avoid.

According to the legislation, now signed into law, every drug that might be given to children - even existing drugs - must be tested in children and, if the drug is approved specifically for pediatric use, child-size doses must be included in the prescribing information.

Currently only eight drugs are actually approved for treating juvenile rheumatoid arthritis in children and, therefore, include pediatric dosage ranges in their labeling: celecoxib (Celebrex), choline and magnesium salicylates (Trilisate), etanercept (Enbrel), ibuprofen (Motrin), indomethacin (Indocin), naproxen (Naprosyn) and tolmetin sodium (Tolectin). Studies of many other drugs are under way, says Dowain Wright, MD, medical director of the division of immunology at Children's Hospital Central California in Madera. And the findings of studies on those drugs can help doctors make educated decisions about the best dosages to prescribe for their young patients.

Increasingly doctors are discovering that the drugs that are effective in adults are also effective for children, says Dr. Wright. As more study results are published and more drugs feature pediatric dosages in their labeling, the hope is that more doctors will have the needed information and confidence to prescribe them - and at the safest, most effective dosages - for their juvenile arthritis patients.

Yours Free: Arthritis Today Drug Guide On Newsstands Now
Get your own copy of the 2007 Drug Guide featured in the 20th Anniversary issue of Arthritis Today magazine.

Arthritis Today
The consumer health magazine published by the Arthritis Foundation six times a year. Order your FREE trial issue today!

EMAIL THIS PAGE